Matthew Beasley

PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer

Waheeda Owadally, Chris Hurt, Hayley Timmins et al. · BMC Cancer · 2015 · 263 citations · Full text

Medicine, Oncology, Oral Surgery +17

Oropharyngeal cancer: United Kingdom National Multidisciplinary Guidelines

Hisham Mehanna, Mark D. Evans, Matthew Beasley et al. · The Journal of Laryngology & Otology · 2016 · 155 citations · Full text

Medicine, Oncology, Radiation Oncology +8

DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer

Imran Petkar, Keith Rooney, Justin Roe et al. · BMC Cancer · 2016 · 111 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Thyroid cancer susceptibility polymorphisms: confirmation of loci on chromosomes 9q22 and 14q13, validation of a recessive 8q24 locus and failure to replicate a locus on 5q24

Angela M. Jones, Kimberley Howarth, Lynn Martin et al. · Journal of Medical Genetics · 2012 · 107 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trial

Christopher M. Nutting, Laura Finneran, Justin Roe et al. · The Lancet Oncology · 2023 · 105 citations · Full text

Medicine, Oncology, Radiation Oncology +17